The BARD1 gene helps repair damaged DNA and works closely with the BRCA1 gene to keep cell growth under control. If the BARD1 gene does not work properly, DNA errors can build up, which may raise the chance of cancer, especially breast cancer. Most variants in this gene have little effect on how your body works, but some inherited variants are linked to a higher cancer risk. BARD1 is mainly known through genetic testing for hereditary cancer risk.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the cell parts that do much of the work. Others mainly control when, where, and how strongly certain processes happen. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. To explore this topic further, you can find more in the LearnHub.
Overview
BARD1Gene function
What if the gene works
The BARD1 gene helps cells repair damaged DNA by working closely with the BRCA1 gene. It also supports controlled cell growth and division, which helps maintain genetic stability.
Risk
What if the gene does not work
More disruptive variants in the BARD1 gene are linked to a higher chance of breast cancer, especially triple negative breast cancer. Milder variants may have smaller effects, so risk, age at diagnosis, and family patterns can vary.
Treatment
What does that mean for your treatment
For advanced prostate cancer, a pathogenic variant in the BARD1 gene can support use of the PARP inhibitor olaparib in guideline-based care. This can influence drug choice after some hormone treatments stop helping. Outside that setting, BARD1-specific treatment guidance is still limited.
Conditions associated with BARD1
Gene function
What if the gene works
Every day, your cells need to copy DNA, fix routine damage, and pause growth when something looks off. A key part of this depends on the BARD1 gene working closely with the BRCA1 gene. This partnership explains much of the BARD1 gene’s role in DNA repair and steady cell growth.
The protein made from the BARD1 gene pairs closely with the BRCA1 protein. This partnership helps both proteins stay stable and reach the places in the cell where repair work is needed.
The BARD1 gene helps your cells fix broken DNA, especially damage that affects both strands. It supports accurate repair so genetic information is maintained during normal cell division.
This gene helps cells slow the cell cycle, meaning the steps of growth and division, when DNA needs attention. That pause gives repair systems time to work before the cell continues dividing.
Together with the BRCA1 gene, the BARD1 gene helps place small chemical tags on selected proteins. These tags act like signals that help organize DNA repair and other routine cell control tasks.
What is a variant?
A genetic variant is a slight change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the BARD1 gene can weaken DNA repair by making the BARD1 protein shorter, unstable, or less able to work with BRCA1. How BARD1 gene variants affect DNA repair depends on the change itself. Milder variants may leave some protein activity, while more disruptive variants can stop the protein from working. This loss of function is linked to a higher chance of breast cancer, with risk varying by the specific variant.
How variants are linked to conditions
Pathogenic variants in the BARD1 gene are linked to a higher chance of breast cancer, with the clearest evidence for inherited breast cancer risk. This link appears especially relevant in some people with triple-negative breast cancer. For many carrying this gene change, risk is increased rather than certain, so a variant in the BARD1 gene does not mean cancer will definitely develop.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a confirmed diagnosis, especially when multiple genes and environmental factors also play a role. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful change in the BARD1 gene, overall cancer risk can be higher if there is a strong family history of breast or related cancers or if other cancer-linked gene changes are also present. The exact effect of lifestyle or environmental factors on BARD1-related risk is not yet clear.
Inheritance of BARD1 variants
For hereditary cancer risk, BARD1 gene variants are usually inherited in an autosomal dominant pattern. That means a parent carrying a disease-associated BARD1 variant can pass it to a son or daughter, and each child has a 50% chance of inheriting that same variant. In practical terms, BARD1 gene inheritance does not depend on sex, so the variant can be passed down through either side of the family. Carrying the variant raises risk, but it does not mean a person will definitely develop cancer.
What does my BARD1 result mean for my family?
A harmful change in the BARD1 gene can run in families in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. For each child of someone with a BARD1 result, the chance is 1 in 2, or 50%. This can matter because family members who carry the change may also have a higher chance of certain cancers, especially breast cancer.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for BARD1 variants uses a blood or saliva sample to read the BARD1 gene and look for changes in its DNA. This can show whether a person carries a benign variant, a variant of uncertain significance, or a pathogenic variant. Results may help clarify inherited cancer risk in a family.
When should I consider getting a genetic test?
Consider BARD1 testing if you or close relatives have had breast cancer, especially at a young age, or a breast cancer type called triple-negative, or if several relatives have had breast or ovarian cancer. It also makes sense if a known BARD1 variant runs in your family. Testing can help clarify inherited cancer risk.
A genetic result is only one part of your health story
A genetic result can provide useful insight, although how much it reveals depends on the condition and the specific type of variant involved. The way the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in the body’s instructions can change how a drug is broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same treatment works well for one person, causes more side effects in another, or seems to have less effect in someone else.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in a person’s genes can shape their response to medications. It examines gene-drug patterns to help explain why the same treatment works differently from one person to another. For many medicines, genes can affect how strongly a drug works or how the body handles it. This information can support more informed, personalized treatment decisions. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the BARD1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so general questions about treatment, side effects, or medication safety are best discussed with your doctor. For BARD1, research is looking at whether certain changes in cancer cells may affect response to some cancer treatments, so people living with cancer and a BARD1 finding may want to review treatment options with their cancer team.
History
The BARD1 gene entered medical research in the late 1990s, when scientists identified it as a key partner of the BRCA1 gene during work on inherited breast and ovarian cancer. Its name came from “BRCA1 associated RING domain 1,” reflecting that early discovery link. From these first observations, research expanded steadily. Investigators then began studying whether inherited variants in the BARD1 gene might also contribute to cancer risk in some families. Over time, larger genetic studies clarified that BARD1 is one of several moderate risk cancer susceptibility genes, especially in relation to breast cancer. This history placed the BARD1 gene within the broader shift from single gene cancer discoveries to more detailed multigene testing.